The system complies with the new Medical Device Regulations that came into force in May 26, 2021. We are happy to announce clearance by the Austrian national authorities (BASG) to start with the study on multimodal molecular retinal diagnostics with the combined Raman and OCT/OCTA platform.It is an initiative of the Photonics Public Private Partnership. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 732969 (MOON). This would have a huge societal impact on the quality of life of patients and their caretakers as well as on the national healthcare systems themselves. Early signs of disease may therefore be diagnosed at an early state in a fully objective manner. The eye serves as window to the brain, as the retinal neural tissue is equally affected by major neurodegenerative diseases as the brain tissue itself. MOON includes a validation of the multimodal diagnostic system in a clinical setting focusing on age-related macula degeneration and Alzheimer’s disease as surrogates for other major diseases affecting the human eye and the brain. The novel diagnostic platform combines the strength of complementary modalities, being Optical Coherence Tomography, Fluorescence Imaging, and Raman Spectroscopy. MOON - Multimodal Optical Diagnosis of Ocular and Neurodegenerative Disease
